Exalenz Bioscience
One-step Urea Breath Test
Company Overview
Snapshot
Founded in April 2006, Exalenz Bioscience operates with 11–50 employees and has raised a total of $10.68 million across four funding rounds. The company was acquired by Meridian Bioscience in May 2020.
Business overview
Exalenz Bioscience develops and commercializes systems that utilize changes in patients' exhaled breath for diagnostic purposes, leveraging its proprietary BreathID technology platform. The company's core technology enables medical specialists to identify and manage specific digestive and liver conditions with clinical precision and patient comfort. Its flagship product, BreathID Hp, is a clinically proven, single-step urea breath test for diagnosing and monitoring H. pylori infection in adults. Exalenz Bioscience operates within the Health Tech & Life Sciences sector, focusing on medical devices, diagnostics devices, and medical monitors, serving healthcare providers and laboratories globally.
Strategic signal
In May 2020, Exalenz Bioscience was acquired by Meridian Bioscience, marking a significant exit for the company and integrating its BreathID technology platform into a larger diagnostic entity. This acquisition validates Exalenz's breath-based diagnostic approach and expands Meridian Bioscience's portfolio with state-of-the-art urea breath test diagnostics.
Log in to access full profile ›Company Intelligence Q&A
- What was a significant corporate milestone for Exalenz Bioscience?
- Exalenz Bioscience was acquired by Meridian Bioscience in May 2020, leading to its inactive status.
- When did Exalenz Bioscience receive FDA clearance for pediatric H. pylori testing?
- Exalenz Bioscience received FDA clearance for pediatric Helicobacter Pylori testing in May 2018.
- Did Exalenz Bioscience collaborate with other pharmaceutical companies?
- In August 2016, Exalenz Bioscience announced a collaboration with Conatus Pharmaceuticals to use BreathID to monitor patients with cirrhosis associated with NASH.
- When did Exalenz Bioscience launch its automated BreathID Hp Lab system?
- Exalenz Bioscience launched its automated BreathID Hp Lab Urea Breath Testing System for Helicobacter pylori detection in August 2017.
- When did Exalenz Bioscience receive approval for commercial marketing in China?
- Exalenz Bioscience received approval for commercial marketing in China for its BreathID Hp Lab System in February 2019.